CNBCMentioned on CNBC's Fast Money as a takeout target now that an activist investor in Sarissa mgmt (Alex Denner) is on the BOD & who engineered the retirement of the president of the co..
Its cancer drug iclusig? is one type of drug (+orphan disease status) that is hot right now in biotech land.
With an activist on the BOD where there's smoke there may be fire, but a one trick pony company is gambling not investing. Hoping for a takeout is a mug's game.
carlos